Publications by the researcher in collaboration with CESAR MORIS DE LA TASSA (46)

2023

  1. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

2022

  1. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

  2. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort

    Life, Vol. 12, Núm. 4

2021

  1. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 5, pp. 1564-1568

2020

  1. Characterization of left ventricular non-compaction cardiomyopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-16

  2. Clinical implications and gender differences of kcnq1 p.Gly168arg pathogenic variant in long qt syndrome

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-12

  3. Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-12

  4. IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association

    Cytokine, Vol. 136

2019

  1. Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease

    Immunology Letters, Vol. 208, pp. 39-43

  2. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 138-144

  3. Spectral analysis of the QT interval increases the prediction accuracy of clinical variables in Brugada syndrome

    Journal of Clinical Medicine, Vol. 8, Núm. 10

2018

  1. Genetic variation at the long noncoding RNA H19 gene is associated with the risk of hypertrophic cardiomyopathy

    Epigenomics, Vol. 10, Núm. 7, pp. 865-873

  2. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing

    Europace, Vol. 20, Núm. FI1, pp. f64-f71

  3. Variants in cardiac GATA genes associated with bicuspid aortic valve

    European Journal of Clinical Investigation, Vol. 48, Núm. 12

2017

  1. Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT

    Epigenomics, Vol. 9, Núm. 8, pp. 1049-1057

  2. Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy

    Journal of Investigative Medicine, Vol. 65, Núm. 5, pp. 926-934

  3. Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients

    Circulation: Cardiovascular Genetics, Vol. 10, Núm. 2

2016

  1. Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families

    International Journal of Cardiology, Vol. 205, pp. 161-162

  2. KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort

    Molecular and Cellular Endocrinology, Vol. 427, pp. 86-91

  3. Next generation sequencing of the NOTCH3 gene in a cohort of pulmonary hypertension patients

    International Journal of Cardiology, Vol. 209, pp. 149-150